Raymond James & Associates Has $9.27 Million Position in Varian Medical Systems, Inc. (VAR)

Raymond James & Associates increased its holdings in Varian Medical Systems, Inc. (NYSE:VAR) by 8.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 83,356 shares of the medical equipment provider’s stock after acquiring an additional 6,218 shares during the period. Raymond James & Associates’ holdings in Varian Medical Systems were worth $9,265,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. APG Asset Management N.V. grew its position in Varian Medical Systems by 6.7% in the fourth quarter. APG Asset Management N.V. now owns 1,780,901 shares of the medical equipment provider’s stock worth $164,846,000 after acquiring an additional 111,482 shares during the period. Wells Fargo & Company MN grew its position in Varian Medical Systems by 7.5% in the fourth quarter. Wells Fargo & Company MN now owns 1,205,836 shares of the medical equipment provider’s stock worth $134,029,000 after acquiring an additional 83,772 shares during the period. Geode Capital Management LLC grew its position in Varian Medical Systems by 4.2% in the fourth quarter. Geode Capital Management LLC now owns 1,186,042 shares of the medical equipment provider’s stock worth $131,599,000 after acquiring an additional 47,590 shares during the period. Ameriprise Financial Inc. grew its position in Varian Medical Systems by 15.1% in the third quarter. Ameriprise Financial Inc. now owns 816,983 shares of the medical equipment provider’s stock worth $81,748,000 after acquiring an additional 106,899 shares during the period. Finally, Renaissance Technologies LLC grew its position in Varian Medical Systems by 438.0% in the fourth quarter. Renaissance Technologies LLC now owns 746,200 shares of the medical equipment provider’s stock worth $82,940,000 after acquiring an additional 607,500 shares during the period. Institutional investors own 99.20% of the company’s stock.

How to Become a New Pot Stock Millionaire

VAR has been the subject of several analyst reports. Citigroup increased their price objective on Varian Medical Systems from $128.00 to $132.00 and gave the stock a “buy” rating in a research report on Thursday, January 25th. Zacks Investment Research upgraded Varian Medical Systems from a “hold” rating to a “buy” rating and set a $142.00 price objective for the company in a research report on Tuesday, March 13th. ValuEngine upgraded Varian Medical Systems from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. TheStreet lowered Varian Medical Systems from a “b+” rating to a “c” rating in a research report on Monday, February 12th. Finally, BTIG Research restated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, January 28th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. Varian Medical Systems presently has a consensus rating of “Hold” and an average price target of $111.80.

Varian Medical Systems, Inc. (NYSE VAR) opened at $119.45 on Monday. Varian Medical Systems, Inc. has a 52-week low of $87.49 and a 52-week high of $130.29. The company has a market capitalization of $10,905.79, a price-to-earnings ratio of 95.56, a PEG ratio of 3.47 and a beta of 0.85.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, topping the consensus estimate of $1.00 by $0.06. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The business had revenue of $678.50 million during the quarter, compared to analyst estimates of $633.96 million. During the same period last year, the business posted $1.09 earnings per share. The company’s quarterly revenue was up 12.8% on a year-over-year basis. analysts forecast that Varian Medical Systems, Inc. will post 4.31 EPS for the current fiscal year.

In other news, EVP Kolleen T. Kennedy sold 699 shares of the stock in a transaction on Monday, March 12th. The stock was sold at an average price of $126.47, for a total value of $88,402.53. Following the sale, the executive vice president now directly owns 27,361 shares in the company, valued at $3,460,345.67. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director David J. Illingworth sold 5,651 shares of the stock in a transaction on Tuesday, March 6th. The shares were sold at an average price of $122.56, for a total value of $692,586.56. Following the completion of the sale, the director now owns 12,737 shares in the company, valued at $1,561,046.72. The disclosure for this sale can be found here. Over the last quarter, insiders sold 100,568 shares of company stock worth $12,019,913. Insiders own 0.78% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Raymond James & Associates Has $9.27 Million Position in Varian Medical Systems, Inc. (VAR)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3302323/raymond-james-associates-has-9-27-million-position-in-varian-medical-systems-inc-var.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Smart Sand  Expected to Post Earnings of $0.08 Per Share
Smart Sand Expected to Post Earnings of $0.08 Per Share
JetPay  Getting Favorable News Coverage, Accern Reports
JetPay Getting Favorable News Coverage, Accern Reports
Glen Burnie Bancorp  Receives News Sentiment Rating of -0.08
Glen Burnie Bancorp Receives News Sentiment Rating of -0.08
MKS Instruments  Releases Q2 Earnings Guidance
MKS Instruments Releases Q2 Earnings Guidance
Vipshop  versus Qurate Retail Group  Critical Contrast
Vipshop versus Qurate Retail Group Critical Contrast
Reviewing Chunghwa Telecom  and Cellcom
Reviewing Chunghwa Telecom and Cellcom


© 2006-2018 Ticker Report. Google+.